Early efficacy and safety of anti–T-lymphocyte globulin (ATLG) induction therapy in renal transplant recipients in China: A multicenter, prospective observational study
Transplant Immunology · 2026-11 · 102475
DOI: 10.1016/j.trim.2026.102475 ↗Kurz gefasst
Fachartikel in der Zeitschrift Transplant Immunology, 2026-11. Verfasst von Yang Li und 26 weiteren Autor:innen. Die Arbeit nennt 18 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Li, Y., Ding, X., Fu, Y., Men, T., Dong, Z., Meng, H., Sun, X., Wu, X., Huang, C., Liu, D., Chen, J., Li, X., Liu, J., Zhang, G., Ma, L., Tan, J., Gao, Z., Yang, H., Liu, Z., …, & Xue, W. (2026). Early efficacy and safety of anti–T-lymphocyte globulin (ATLG) induction therapy in renal transplant recipients in China: A multicenter, prospective observational study. Transplant Immunology, 102475. https://doi.org/10.1016/j.trim.2026.102475
Vancouver
Li Y, Ding X, Fu Y, Men T, Dong Z, Meng H, et al. Early efficacy and safety of anti–T-lymphocyte globulin (ATLG) induction therapy in renal transplant recipients in China: A multicenter, prospective observational study. Transplant Immunology. 2026:102475. doi:10.1016/j.trim.2026.102475
BibTeX
@article{Li2026,
author = {Li, Yang and Ding, Xiaoming and Fu, Yaowen and Men, Tongyi and Dong, Zhen and Meng, Huilin and Sun, Xun and Wu, Xiaotong and Huang, Chibing and Liu, Dong and Chen, Jianghua and Li, XinChang and Liu, Jian and Zhang, Guoqing and Ma, Lulin and Tan, Jianming and Gao, Zhenli and Yang, Hongji and Liu, Zhizhong and Wang, Changan and Liu, Hang and Xiao, Jiaquan and Wei, Jian and Kang, Xinli and Fu, Yingxin and Zhang, Xiaodong and Xue, Wujun},
title = {Early efficacy and safety of anti–T-lymphocyte globulin (ATLG) induction therapy in renal transplant recipients in China: A multicenter, prospective observational study},
journal = {Transplant Immunology},
year = {2026},
pages = {102475},
doi = {10.1016/j.trim.2026.102475}
}
EUVIMED